IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

IGOR VOLKOV

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1588810162
CMS profile
162255
Location
WASHINGTON, DC

General Payments · PY2018–2024

$8,816.56

  • Reported across 193 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$3,342.63

53 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatry DC All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,092.38 50
Education $250.25 3

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Teva Pharmaceuticals USA, Inc. $944.64 15
Vanda Pharmaceuticals Inc. $504.91 6
Neurocrine BioSciences, Inc. $358.56 5
Janssen Pharmaceuticals, Inc $336.91 6
Otsuka America Pharmaceutical, Inc. $322.99 8
E.R. Squibb & Sons, L.L.C. $268.27 3
Alkermes, Inc. $238.78 3
ABBVIE INC. $183.25 4
ITI, Inc. $138.76 1
Indivior Inc. $45.56 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,026.01 27
PY2019 $1,347.74 26
PY2020 $129.42 2
PY2021 $41.57 2
PY2022 $920.04 25
PY2023 $2,009.15 58
PY2024 $3,342.63 53

Payment records · PY2024 (53)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $23.06 01/31/2024 Food and Beverage Undisputed 01/23/2026 1106291324 CMS
ABBVIE INC. $27.20 03/06/2024 Food and Beverage Undisputed 01/23/2026 1106291326 CMS
ABBVIE INC. $124.78 03/21/2024 Food and Beverage Undisputed 01/23/2026 1106291328 CMS
ABBVIE INC. $8.21 04/23/2024 Food and Beverage Undisputed 01/23/2026 1106291330 CMS
Alkermes, Inc. $94.54 02/15/2024 Food and Beverage Undisputed 01/23/2026 1120615238 CMS
Alkermes, Inc. $18.77 08/18/2024 Food and Beverage Undisputed 01/23/2026 1120615240 CMS
Alkermes, Inc. $125.47 10/16/2024 Food and Beverage Undisputed 01/23/2026 1120615242 CMS
E.R. Squibb & Sons, L.L.C. $122.11 09/12/2024 Food and Beverage Undisputed 01/23/2026 1101806694 CMS
E.R. Squibb & Sons, L.L.C. $27.27 10/08/2024 Education Undisputed 01/23/2026 1101806675 CMS
E.R. Squibb & Sons, L.L.C. $118.89 12/04/2024 Food and Beverage Undisputed 01/23/2026 1101806716 CMS
Indivior Inc. $21.22 01/30/2024 Food and Beverage Undisputed 01/23/2026 1144540123 CMS
Indivior Inc. $24.34 05/22/2024 Food and Beverage Undisputed 01/23/2026 1144540125 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $138.76 10/23/2024 Food and Beverage Undisputed 01/23/2026 1143339755 CMS
Janssen Pharmaceuticals, Inc $28.84 02/20/2024 Food and Beverage Undisputed 01/23/2026 1077951872 CMS
Janssen Pharmaceuticals, Inc $148.90 02/21/2024 Food and Beverage Undisputed 01/23/2026 1077952046 CMS
Janssen Pharmaceuticals, Inc $35.20 05/14/2024 Food and Beverage Undisputed 01/23/2026 1077952430 CMS
Janssen Pharmaceuticals, Inc $79.89 05/23/2024 Food and Beverage Undisputed 01/23/2026 1077952382 CMS
Janssen Pharmaceuticals, Inc $6.36 08/10/2024 Food and Beverage Undisputed 01/23/2026 1077951960 CMS
Janssen Pharmaceuticals, Inc $37.72 08/10/2024 Food and Beverage Undisputed 01/23/2026 1077952152 CMS
Neurocrine Biosciences, Inc. $174.78 06/24/2024 Food and Beverage Undisputed 01/23/2026 1150806084 CMS
Neurocrine Biosciences, Inc. $21.01 08/03/2024 Food and Beverage Undisputed 01/23/2026 1150854617 CMS
Neurocrine Biosciences, Inc. $2.10 08/03/2024 Food and Beverage Undisputed 01/23/2026 1150891085 CMS
Neurocrine Biosciences, Inc. $25.31 09/09/2024 Food and Beverage Undisputed 01/23/2026 1150839030 CMS
Neurocrine Biosciences, Inc. $135.36 09/24/2024 Food and Beverage Undisputed 01/23/2026 1150807848 CMS
Otsuka America Pharmaceutical, Inc. $23.19 01/23/2024 Food and Beverage Undisputed 01/23/2026 1119000655 CMS
Otsuka America Pharmaceutical, Inc. $27.90 02/06/2024 Food and Beverage Undisputed 01/23/2026 1119000657 CMS
Otsuka America Pharmaceutical, Inc. $0.40 05/20/2024 Food and Beverage Undisputed 01/23/2026 1119000659 CMS
Otsuka America Pharmaceutical, Inc. $27.91 05/21/2024 Food and Beverage Undisputed 01/23/2026 1119000661 CMS
Otsuka America Pharmaceutical, Inc. $102.30 06/11/2024 Food and Beverage Undisputed 01/23/2026 1119000663 CMS
Otsuka America Pharmaceutical, Inc. $8.65 08/20/2024 Food and Beverage Undisputed 01/23/2026 1119000665 CMS
Otsuka America Pharmaceutical, Inc. $121.83 11/13/2024 Food and Beverage Undisputed 01/23/2026 1119000667 CMS
Otsuka America Pharmaceutical, Inc. $10.81 11/19/2024 Food and Beverage Undisputed 01/23/2026 1119000669 CMS
Teva Pharmaceuticals USA, Inc. $14.85 01/08/2024 Food and Beverage Undisputed 01/23/2026 1151670147 CMS
Teva Pharmaceuticals USA, Inc. $120.94 01/18/2024 Food and Beverage Undisputed 01/23/2026 1151670158 CMS
Teva Pharmaceuticals USA, Inc. $129.29 01/25/2024 Food and Beverage Undisputed 01/23/2026 1151670162 CMS
Teva Pharmaceuticals USA, Inc. $120.23 02/08/2024 Food and Beverage Undisputed 01/23/2026 1151670183 CMS
Teva Pharmaceuticals USA, Inc. $9.94 02/13/2024 Food and Beverage Undisputed 01/23/2026 1151670165 CMS
Teva Pharmaceuticals USA, Inc. $22.50 03/05/2024 Food and Beverage Undisputed 01/23/2026 1151670195 CMS
Teva Pharmaceuticals USA, Inc. $19.85 03/12/2024 Food and Beverage Undisputed 01/23/2026 1151670198 CMS
Teva Pharmaceuticals USA, Inc. $119.44 04/11/2024 Food and Beverage Undisputed 01/23/2026 1151670422 CMS
Teva Pharmaceuticals USA, Inc. $9.21 04/16/2024 Food and Beverage Undisputed 01/23/2026 1151670231 CMS
Teva Pharmaceuticals USA, Inc. $16.64 06/03/2024 Food and Beverage Undisputed 01/23/2026 1151670274 CMS
Teva Pharmaceuticals USA, Inc. $8.29 06/12/2024 Food and Beverage Undisputed 01/23/2026 1151670321 CMS
Teva Pharmaceuticals USA, Inc. $111.49 06/17/2024 Education Undisputed 01/23/2026 1151670426 CMS
Teva Pharmaceuticals USA, Inc. $121.83 08/20/2024 Food and Beverage Undisputed 01/23/2026 1151670448 CMS
Teva Pharmaceuticals USA, Inc. $111.49 09/13/2024 Education Undisputed 01/23/2026 1151670429 CMS
Teva Pharmaceuticals USA, Inc. $8.65 09/24/2024 Food and Beverage Undisputed 01/23/2026 1151670488 CMS
Vanda Pharmaceuticals Inc. $123.00 01/23/2024 Food and Beverage Undisputed 01/23/2026 1133925400 CMS
Vanda Pharmaceuticals Inc. $18.40 02/28/2024 Food and Beverage Undisputed 01/23/2026 1133925404 CMS
Vanda Pharmaceuticals Inc. $125.48 03/27/2024 Food and Beverage Undisputed 01/23/2026 1133925408 CMS
Vanda Pharmaceuticals Inc. $122.75 07/09/2024 Food and Beverage Undisputed 01/23/2026 1133925412 CMS
Vanda Pharmaceuticals Inc. $19.26 07/09/2024 Food and Beverage Undisputed 01/23/2026 1133925416 CMS
Vanda Pharmaceuticals Inc. $96.02 09/03/2024 Food and Beverage Undisputed 01/23/2026 1133925420 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.